Overall, this study provides an insight on how HIV-1 gp120 clades B and C differ in neuropathogenesis by providing the basis for the development of new complementary therapeutic approaches to treat HAND. The gene discussed is ITIH4; the disease is HIV-associated neurocognitive disorder.